论文部分内容阅读
目的探讨布地奈德混悬液雾化吸入治疗术后老年慢性鼻-鼻窦炎患者的临床疗效。方法选取2014年8月—2016年8月于德昌县人民医院行手术治疗的慢性鼻-鼻窦炎患者72例,随机分为对照组和观察组,各36例。对照组患者采用布地奈德喷雾剂进行喷鼻治疗,观察组采用吸入用布地奈德混悬液雾化吸入治疗,两组患者均持续治疗3周。比较两组患者治疗前后鼻内镜评分量表(Kennedy)评分及临床疗效。结果治疗前,两组患者Kennedy评分比较,差异无统计学意义(P>0.05);治疗后,观察组患者Kennedy评分低于对照组(P<0.05)。观察组患者临床疗效优于对照组(P<0.05)。结论采用吸入用布地奈德混悬液雾化吸入治疗术后老年慢性鼻-鼻窦炎患者的临床疗效确切,可有效改善黏膜水肿,促进疾病恢复。
Objective To investigate the clinical efficacy of inhaled budesonide in the treatment of postoperative elderly patients with chronic rhinosinusitis. Methods Seventy-two patients with chronic rhinosinusitis who were surgically treated in Dechang County People’s Hospital from August 2014 to August 2016 were randomly divided into control group and observation group, with 36 cases in each group. Patients in the control group received budesonide spray for nasal spray, while those in the observation group received inhaled budesonide suspension for nebulization. Patients in both groups continued to be treated for 3 weeks. The Kennedy score and clinical efficacy of the two groups before and after treatment were compared. Results Before treatment, Kennedy scores of two groups had no significant difference (P> 0.05). After treatment, Kennedy score of observation group was lower than that of control group (P <0.05). The clinical efficacy of the observation group was better than that of the control group (P <0.05). Conclusion The inhalation of budesonide suspension inhalation for the treatment of senile chronic rhinosinusitis patients with clinical curative effect is exact, can effectively improve mucosal edema and promote disease recovery.